Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

Tue, 13th Feb 2024 16:53

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

The FTSE 100 index closed down 61.41 points, 0.8%, at 7,512.28. The FTSE 250 ended down 280.10 points, 1.5%, at 18,923.83, and the AIM All-Share closed down 2.85 points, 0.4%, at 747.33.

The Cboe UK 100 ended down 0.9% at 750.56, the Cboe UK 250 closed down 1.7% at 16,341.91, and the Cboe Small Companies ended down 0.2% at 14,364.40.

In European equities on Tuesday, the CAC 40 in Paris and the DAX 40 in Frankfurt both closed down 0.9%.

Stocks in New York were lower at the London equities close, with the DJIA down 1.1%, the S&P 500 index down 1.0%, and the Nasdaq Composite down 1.2%.

The US inflation rate cooled but at a slower pace than expected last month, key figures on Tuesday showed.

According to the Bureau of Labor Statistics, the nation's consumer price inflation rate eased to 3.1% in January, from 3.4% in December. It had been expected to ebb to 2.9%, according to FXStreet cited consensus, so the latest reading topped expectations.

Annual core inflation, so excluding food and energy, was steady at 3.9% in January, defying expectations of a slowdown to 3.7%.

"US inflation failed to moderate as hoped with housing costs, air fares, medical care and recreation all keeping the run rate for month-on-month inflation hot. Their favoured measure of inflation, the core PCE deflator, may be cooling nicely, but the mixed messages means the Fed can't relax, with little inclination for imminent rate cuts," said ING's James Knightley.

The reading all but ensures that any tiny thread of hope that the Federal Reserve will cut interest rates next month were extinguished. Investors are looking to May for the first Fed cut of the year, though Tuesday's data could dampen that hope.

Ebury's Matthew Ryan said that a May cut is now "in serious jeopardy."

Ryan added: "We stand by our call for a start to the Fed's cutting cycle in June, albeit this would also be thrown in doubt should US inflation continue to surprise to the upside, while the labour market shows no signs of slowing down."

The dollar was mostly stronger on the back of the reading.

The pound was quoted at USD1.2596 at the London equities close Tuesday, down compared to USD1.2621 at the close on Monday. The euro stood at USD1.0716 at the European equities close Tuesday, down against USD1.0769 at the same time on Monday.

Against the yen, the dollar was trading at JPY150.66, higher compared to JPY149.44 late Monday.

Meanwhile, in the UK, there was also some key economic data for investors to digest.

According to the Office for National Statistics, the jobless rate faded to 3.8% in the three months to the end of December from 4.2% in the period from September to November.

Unemployment had been expected to ease slightly less, to 4.0%, according to FXStreet-cited market consensus.

Annual growth in regular earnings, so excluding bonuses, amounted to 6.2% in the three months to December. Including bonuses, earnings rose 5.8% on-year.

Pay growth was hotter than expected by both measures. Earnings including bonuses had been expected to rise by 5.6%, according to FXStreet, while excluding bonuses, a rise of 6.0% was forecast.

"Stronger than expected labour data from the UK didn't help matters as it effectively gives the Bank of England another reason to keep rates steady and not rush to cut them," AJ Bell's Russ Mould explained.

The BoE's next decision is on March 21.

On Wednesday, the ONS reports UK inflation data for January. Annual consumer price inflation is expected to have picked up to 4.2% last month from 4.0% in December, according to FXStreet.

In London, property firms were among the worst large-cap performers following the red-hot UK data.

Property portal Rightmove fell 3.0%, while housebuilders Taylor Wimpey, Persimmon, and Barratt Developments fell 4.4%, 4.1% and 4.6%.

There were just eight FTSE 100 companies in the green. Amogst them, pharmaceutical firms AstraZeneca and GSK were up 1.0% and 1.1%, respectively.

In the FTSE 250, Tui shares closed up 0.8%.

Tui's pretax loss narrowed to EUR103.1 million in the three months that ended December 31 from EUR272.6 million a year before, as revenue rose by 15% to a "record" EUR4.30 billion from EUR3.75 billion.

On London's AIM, Saietta plummeted 54%.

The Towcester, England-based manufacturer said it would be selling a redundant production line after missing out on a potentially lucrative manufacturing contract.

The company has received a proposal of GBP600,000 from an unnamed buyer for the purchase of a redundant production line at its Sunderland manufacturing site.

Saietta said that the sale is the result of the company being unable to reach a commercial agreement for a contract to product electrical steering pumps at the Sunderland plant.

Brent oil was quoted at USD82.93 a barrel at the London equities close Tuesday, up from USD81.69 late Monday.

Gold was quoted at USD1,995.88 an ounce at the London equities close Tuesday, lower against USD2,013.55 at the close on Monday.

In Wednesday's UK corporate calendar, there are full year results from Coca-Cola HBC. There are also trading statements from Severn Trent and United Utilities.

The economic calendar for Wednesday has a gross domestic product reading for the eurozone at 1000 GMT, as well as employment data.

For the UK, there are CPI and PPI readings at 0700 GMT. Further at 1500 GMT, Bank of England Governor Andrew Bailey will speak.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved..

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.